What is it about?
This article is about detailing of various patents related to Bortezomib.
Featured Image
Why is it important?
This article helps a researcher to refer the related patents at one place with comprehensive review.
Perspectives
Writing this article was a great pleasure as it has co-authors with whom I have had long standing collaborations.
Pratik Vora
Read the Original
This page is a summary of: Bortezomib – First Therapeutic Proteasome Inhibitor for Cancer Therapy: A Review of Patent Literature, Recent Patents on Anti-Cancer Drug Discovery, October 2020, Bentham Science Publishers,
DOI: 10.2174/1574892815666200401113805.
You can read the full text:
Contributors
The following have contributed to this page
